Journal
BRITISH JOURNAL OF CANCER
Volume 92, Issue 9, Pages 1599-1610Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6602550
Keywords
biomarker; magnetic resonance; therapeutic trials; antiangiogenic; antivascular; cancer therapy
Categories
Ask authors/readers for more resources
Vascular and angiogenic processes provide an important target for novel cancer therapeutics. Dynamic contrast-enhanced magnetic resonance imaging is being used increasingly to noninvasively monitor the action of these therapeutics in early-stage clinical trials. This publication reports the outcome of a workshop that considered the methodology and design of magnetic resonance studies, recommending how this new tool might best be used.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available